Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Synchro SELECT Guidewire

K-Number: K202522 · 2020-09-25

Decision Date2020-09-25
Product CodeMOF
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Synchro SELECT Guidewire is a medical device manufactured by Stryker Neurovascular. It received FDA 510(k) clearance on 2020-09-25 under approval number K202522. The device is classified under product code MOF. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Synchro SELECT Guidewire?

Synchro SELECT Guidewire is a medical device that received FDA 510(k) clearance on 2020-09-25. It is manufactured by Stryker Neurovascular. The 510(k) number is K202522.

When was Synchro SELECT Guidewire approved by the FDA?

Synchro SELECT Guidewire received FDA 510(k) clearance on 2020-09-25, under approval number K202522.

What company makes Synchro SELECT Guidewire?

Synchro SELECT Guidewire is manufactured by Stryker Neurovascular.

What is the FDA product code for Synchro SELECT Guidewire?

The FDA product code for Synchro SELECT Guidewire is MOF.

Related Clinical Trials

Other Devices by Stryker Neurovascular

View all 26 devices →

Related Devices (Code: MOF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.